Promoter group acquires shares via preferential allotment on share swap basis

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

—Next day

₹143.90

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%—

Computers - Software & Consulting peers, median of 65sector+1.2%—

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—+0.3—+1.6—

Next day

—+1.1—+1.2—

+0.0+1.3-1.3+2.9-2.9

+0.0+2.0-2.0+3.9-3.9

+0.0+0.3-0.3+4.4-4.4

+0.0+1.1-1.1+5.5-5.5

+0.0-3.2+3.2+2.3-2.3

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Computers - Software & Consulting peers, median of 65Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

iSERA Lifesciences allotted equity shares to 31 promoter group members via preferential allotment on a share swap basis. Date of allotment: Oct 1, 2026. Largest allottee Shubhangi Garad received 27.55 lakh shares (4.95%), followed by Sumeet Garad with 11.92 lakh shares (4.06%). Other allottees received between 25,000 to 7.85 lakh shares each. All shares were issued on a swap basis with no cash inflow to the company.

Likely market impact

Promoter group holding increases via share swap; no cash raised. Dilution for existing non-promoter shareholders but aligns promoter skin in the game.